Company Data
Moleculin Biotech Inc.
Ticker
MBRX
Current Price
$1.28 -8.57%
Market Cap
$3.8M
Price Target
Refer to Report
Volume
1.6M
52wk Range
$0.3975 - $10.35
Overview
Moleculin Biotech Inc is a clinical-stage pharmaceutical company. The firm focus on the development of oncology drug candidates. The drug technologies used by the company are anthracycline, a portfolio of STAT3 inhibitors, and collection of inhibitors of glycolysis.